Revance Therapeutics Expands Leadership Team

Mar 14, 2016

REVANCE THERAPEUTICS EXPANDS LEADERSHIP TEAM, APPOINTS ROMAN G. RUBIO, MD, MBA, AS SENIOR VICE PRESIDENT OF CLINICAL DEVELOPMENT

NEWARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) — Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing botulinum toxin products for use in aesthetic and therapeutic indications, today announced a key addition to its leadership team with the appointment of Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Development, effective immediately. Dr. Rubio will report to Chief Operating Officer Abhay Joshi, and will lead the company’s clinical development team, focusing on further accelerating the advancement of Revance’s neurotoxin development programs.

About ON Partners

In a high-tech world, our difference is human. ON Partners is a pure-play retained executive search firm building C-level and board leadership teams for high-growth private and public companies, private equity, and venture capital.

With a partner-led, high-touch model, clients gain direct access to seasoned partners who lead every search from day one to day done. Our boutique structure enables speed, agility, and precision. This hands-on approach fosters a deep understanding of client needs, delivers elite talent quickly, and ensures unmatched responsiveness.

ON Partners is the most referred executive search firm in the industry. And the numbers back it up— 85% of our clients return, 95% of new business comes from referrals, and clients and candidates rate their experience with us 4.9 out of 5.

Consistently ranked among the top 20 retained executive search firms in the U.S., ON Partners has been recognized by Forbes as one of America’s Best Executive Recruiting Firms and has appeared on the Inc. 500/5000 List nine times.

Our Approach Works.

Contact Us

Revance Therapeutics Expands Leadership Team